Avita Medical (ASX:AVH) yesterday announced it appointed David McIntyre as chief financial officer, effective Nov. 18.
McIntyre will be responsible for overseeing global finance and investor relations. He replaces interim CFO Tim Rooney, who will continue as the company’s chief administrative officer.
“David’s extensive background in global finance, operations and law, in combination with his experience as a senior executive and corporate advisor with life sciences and device companies listed on multiple stock exchanges, strengthens our leadership team at a pivotal time,” CEO Mike Perry said in a news release. “I want to thank Tim for his service as interim CFO and am delighted to have David on board as we position the company for continued growth, building on the successful U.S. commercial launch of the Recell System and further developing our pipeline across multiple indications.”
Prior to joining Avita Medical, McIntyre was executive VP, CFO and chief operating officer at HeartWare International. He also previously served as a partner at Apple Tree Partners where he was responsible for the venture capital’s medical device portfolio. He has also held a number of senior financial, legal and operational roles.